The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment.

Authors:
Lawn W; Trinci K; Mokrysz C; Borissova A; Ofori S and 11 more

Journal:
Addiction

Publication Year: 2023

DOI:
10.1111/add.16154

PMCID:
PMC10481756

PMID:
36750134

Journal Information

Full Title: Addiction

Abbreviation: Addiction

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Substance-Related Disorders

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"DECLARATION OF INTERESTS W.L., K.T., C.M., A.B., S.O., M.B., Z.H., D.H., N.F.V., S.W., A.E., T.P.F. and H.V.C. declare no competing interests. A.E. has received speaker's honoraria from Jazz Pharmaceuticals. M.W. is primarily employed by Invicro."

Evidence found in paper:

"Funding information This study was funded by the Medical Research Council (MR/P012728/1 to H.V.C. and T.P.F.)."

Evidence found in paper:

"This was a single‐centre study conducted at University College London and Invicro (Hammersmith Hospital, United Kingdom [UK]). We recruited healthy participants from the community in London, UK. The study received full ethical approval from UCL Ethics Committee (project code: 5929/005). This study was registered on Clinical.Trials.gov (NCT04851392). All participants provided written, informed consent and provided verbal ongoing consent at the beginning of each study session."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025